80466-79-1Relevant articles and documents
Development of novel NLRP3-XOD dual inhibitors for the treatment of gout
Wang, Weiwei,Pang, Jing,Ha, Eun Hee,Zhou, Mengze,Li, Zhubin,Tian, Sheng,Li, Huanqiu,Hu, Qinghua
supporting information, (2020/01/13)
Gout is a crystalline-related arthropathy caused by the deposition of monosodium urate (MSU). Acute gouty arthritis is the most common first symptom of gout. Studies have shown that NOD-like receptor protein 3 (NLRP3) inflammasome as pattern recognition r
Bispiperidines as antithrombotic agents
-
, (2008/06/13)
Novel compounds which are inhibitors of the binding of fibrinogen to the Gp IIb/IIIa platelet receptors, and which can be used therepeutically as antithrombotic agents
Some Heterocyclic Sulfonyl Chlorides and Derivatives
Cremlyn, Richard J.,Swinbourne, Fred J.,Yung, Kin-Man
, p. 997 - 1006 (2007/10/02)
The syntheses of 4- and 5-chlorosulfonylfuran-2-carboxylic acid (Ia,IIa), 4-chlorosulfonylfuran-2-carboxamide (Ib), 3,5-dimethylpyrazole and isoxazole-4-sulfonyl chlorides (IIa, IVa) and 2,4-dimethylthiazole-5-sulfonyl chloride (Va) are described.The sulf